意义未明单克隆丙种球蛋白病、冒烟型骨髓瘤和多发性骨髓瘤患者的基质细胞改变
研究比较意义未明单克隆丙种球蛋白病(MGUS)、冒烟型骨髓瘤(SMM)和多发性骨髓瘤(MM)患者骨髓间充质干细胞(MSC)的特性与功能,并行信使RNA测序。MGUS期MSC已出现衰老细胞增多、成骨分化能力及造血支持下降,BMP/TGF信号通路相关差异基因在MGUS即可检出,并在SMM和MM患者中明显增加。
要点
- MGUS期MSC已出现衰老细胞增多、成骨分化能力与造血支持下降。
- BMP/TGF信号通路差异表达基因在MGUS即可检出,SMM和MM中明显增加。
- 作者认为上述数据未来可能有助于阻断这些信号通路以阻止进展为MM。
核心结论
- MGUS期即已存在MSC衰老增多、成骨分化能力与造血支持下降,BMP/TGF信号通路差异基因在MGUS可检出并在SMM和MM中明显增加。
- 作者认为这些数据未来可能有助于阻断相关信号通路以阻止进展为MM。
研究设计与样本
- 研究分析MGUS、SMM和MM患者的MSC,评估其特性与功能,并行信使RNA测序以寻找不同疾病阶段的分子特征。
- 原文未报告样本量、中心数量及研究类型。
主要发现
- MGUS的MSC中已存在大量衰老细胞,成骨分化能力和造血支持下降。
- RNA测序显示存在广谱差异表达基因,包括BMP/TGF信号通路基因,在MGUS即可检出,并在SMM和MM患者中明显增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The hallmark of multiple myeloma (MM) is a clonal plasma cell infiltration in the bone marrow accompanied by myelosuppression and osteolysis. Premalignant stages such as monoclonal gammopathy of undetermined significance (MGUS) and asymptomatic stages such as smoldering myeloma (SMM) can progress to MM. Mesenchymal stromal cells (MSCs) are an integral component of the bone marrow microenvironment and play an important role in osteoblast differentiation and hematopoietic support. Although stromal alterations have been reported in MM contributing to hematopoietic insufficiency and osteolysis, it is not clear whether alterations in MSC already occur in MGUS or SMM. In this study, we analyzed MSCs from MGUS, SMM, and MM regarding their properties and functionality and performed messenger RNA sequencing to find underlying molecular signatures in different disease stages. A high number of senescent cells and a reduced osteogenic differentiation capacity and hematopoietic support were already present in MGUS MSC. As shown by RNA sequencing, there was a broad spectrum of differentially expressed genes including genes of the BMP/TGF-signaling pathway, detected already in MGUS and that clearly increases in patients with SMM and MM. Our data may help to block these signaling pathways in the future to hinder progression to MM.
引用
- Bogun L, Koch A, Scherer B, et al. Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma. Blood Adv. 2024. PMID: 38241490. doi:10.1182/bloodadvances.2023011632
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。